BriaCell Therapeutics Corp. Stock Performance

Open $3.50	Prev. Close $3.61	Circuit Range N/A
Day Range $3.50 - $3.50	Year Range $2.60 - $13.28	Volume 1,125
Average Traded $3.50

BriaCell Therapeutics Corp. Share Price Today

As of 29 October 2026, BriaCell Therapeutics Corp.'s share price is $3.50. The stock opened at $3.50, compared to its previous close of $3.61. During today's trading session, BriaCell Therapeutics Corp.'s share price traded between $3.50 and $3.50, with an average price of $3.50. Over the past 52 weeks, the stock has recorded a high of $13.28 and a low of $2.60. In terms of performance, BriaCell Therapeutics Corp.'s share price has declined by 16.27% over the last six months and is down 70.41% on a year-on-year basis.

BriaCell Therapeutics Corp. Share Price Chart

$3.50$3.50

BriaCell Therapeutics Corp. Stock Fundamentals & Key Indicators

Market Cap $1.48M	PE Ratio (TTM) N/A	Dividend Yield 0.00%
EPS (TTM) $-3.53	Revenue (TTM) $0.00	Return On Equity (TTM) -127.51%
Profit Margin N/A	Debt to Equity 0.00	Quarterly Earnings Growth YoY 11.50%

BriaCell Therapeutics Corp. Quarterly Profit & Loss

All figures in USD

Particulars	Jul 2025	Oct 2025	Jan 2026	Apr 2026
Revenue	$0.00	$0.00	$0.00	$0.00
Net Profit	-$8.09	-$8.20	-$7.22	-$7.16
Net Profit Margin	N/A	N/A	N/A	N/A
Income Change	N/A	-1.36%	11.95%	0.83%

BriaCell Therapeutics Corp. Annual Profit & Loss

All figures in USD

Particulars	2022	2023	2024	2025
Revenue	$0.00	$0.00	$0.00	$0.00
Net Profit	-$26.84	-$20.30	-$4.79	-$26.31
Net Profit Margin	N/A	N/A	N/A	N/A
Income Change	N/A	24.37%	76.40%	-449.27%

About BriaCell Therapeutics Corp.

BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.

BriaCell Therapeutics Corp. Historical Returns

Month	Open	Close	Change %
Oct 2026	$4.16	$3.50	-17.84%
Sep 2026	$3.63	$4.26	+13.90%
Aug 2026	$3.40	$3.74	+3.89%
Jul 2026	$3.40	$3.60	+10.60%
Jun 2026	$3.27	$3.25	-9.83%
May 2026	$4.25	$3.61	-13.64%
Apr 2026	$4.22	$4.18	-0.48%
Mar 2026	$3.69	$4.20	+10.82%
Feb 2026	$4.28	$3.79	-11.96%
Jan 2026	$7.06	$4.30	-39.71%
Dec 2025	$12.29	$7.14	-26.39%
Nov 2025	$10.14	$9.70	-18.01%

BCTX Share Price FAQs

What is BriaCell Therapeutics Corp. share price today?

BriaCell Therapeutics Corp. share price today is $3.50 as on October 29, 2026 at 1:22 am IST.

What is the 52 week high and 52 week low of BriaCell Therapeutics Corp. stock?

The 52 week high of BriaCell Therapeutics Corp. stock is $13.28, while the 52 week low is $2.60 as of 29 Oct '26.

What is BCTX's market capitalisation today?

BCTX market capitalisation is $1.48M as of October 29, 2026, at 2:05 am IST.

What is BCTX's net income for the last quarter?

BCTX's net income for the last quarter is -7.16B USD.

What is the 5 year returns of BCTX?

The 5 year returns of BCTX is -97.06% as on 29 Oct '26.

What is the high & low stock price of BCTX today?

BCTX stock price hit a high of $3.50 and low of $3.50 as of 29 Oct '26.

Can I buy BCTX shares in India?

Yes. You can buy BCTX in India by opening an international trading account.